Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Terran Prime
New York, New York, United Statesterranprime.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Terran Biosciences has a portfolio of late-stage therapeutics and technologies targeting neurological and psychiatric diseases. Lead programs include TerXT, a novel prodrug combination for schizophrenia, and Idazoxan XR, an extended-release alpha 2 adrenergic antagonist with demonstrated efficacy in Phase 2 studies. The company also offers NM‑101, the first FDA-cleared neuromelanin MRI analysis software. Terran’s pipeline leverages proprietary medicinal chemistry and AI-enabled platforms to advance CNS drug development.[1]
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculeProdrug (for TerXT)Extended-release formulation (for Idazoxan XR)Software as a medical device (NM‑101 platform)Psychedelic therapy (psilocybin derivatives)
- Industry
- Biotech
02
Partnerships
Pierre Fabre (licensing partner for idazoxan)[1]
Beyond the preview
Go deeper on Terran Prime.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Terran Prime.